Research Trials: Oncology
For more information, please contact Suburban Hospital Oncology Research:
Barbara Squiller: 301-896-2719
Melissa Hyman: 301-896-3221
| Topic | Study Name | Learn More | Principal Investigator |
| Breast | Molecular Genetic Studies in Cancer | Call 301-896-2719 or 301-896-3221. | Carolyn Hendricks, M.D. |
| Breast | YOUNG AND STRONG: An Education and Supportive Care Intervention Study for Young Women with Breast Cancer | Learn More | Carolyn Hendricks, M.D. |
| Breast | A Phase III Randomized Trial of Metformin versus Placebo on Recurrence and Survival in Early Stage Breast Cancer | Learn More | Carolyn Hendricks, M.D. |
| Breast | A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer | Learn More | Carolyn Hendricks, M.D. |
| Breast | A Phase III Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer with Recurrence Score (RS) of 25 or Less. | Learn More | Carolyn Hendricks, M.D. |
| Breast | Phase II placebo-controlled trial of lisinopril and Coreg CR® to reduce cardiotoxicity in patients with breast cancer receiving (neo)adjuvant chemotherapy with trastuzumab (Herceptin®) | Learn More | Carolyn Hendricks, M.D. |
| Breast | A Study to Evaluate Different Decision-Making Approaches Used by Women Known to be at Increased Risk for Breast Cancer | Learn More | Carolyn Hendricks, M.D. |
 |
Oncology Research Team |